Download PDF
Thromb Haemost 1996; 75(02): 298-302
DOI: 10.1055/s-0038-1650264
Original Article
Schattauer GmbH Stuttgart

The Production of Heparin Cofactor li Is Not Regulated by Inflammatory Cytokines in Human Hepatoma Cells: Comparison with Plasminogen Activator Inhibitor Type-1

Chisato Kolke
1   The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan
2   Third Department of Internal Medicine, Faculty of Medicine, Yamagata University, Yamagata, Japan
,
Yumiko Hayakawa
1   The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan
,
Kenji Niiya
1   The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan
,
Nobuo Sakuragawa
1   The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan
,
Hideo Sasaki
2   Third Department of Internal Medicine, Faculty of Medicine, Yamagata University, Yamagata, Japan
› Author Affiliations
Further Information

Publication History

Received: 30 August 1995

Accepted after revision06 November 1995

Publication Date:
26 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Using the Northern blot technique, we screened 6 human hepatoma cell lines to investigate the regulation mechanism of heparin cofactor II (HCII) biosynthesis. We found that HuH-7 and Hep G2 cells constitutively expressed the HC II gene. In conditioned medium, HuH-7 cells constantly produced HC II that was functionally active and formed a complex with thrombin in the presence of dermatan sulfate. HC II is thought be an acute phase reactant, and, therefore, we examined the effects of the major inflammatory cytokines, IL-6, IL-1β, and TNF-α, on the regulation of HC II production in HuH-7 and Hep G2 cells. In HuH-7 cells, the antigen and mRNA levels of plasminogen activator inhibitor type-1 (PAI-1), an acute phase protein produced by hepa-tocytes, were increased in response to stimulation with either IL-6 or IL-1 (3 or both, but HC II antigen and mRNA levels were not changed by the same stimulation. Even when Hep G2 cells were treated with a combination of three cytokines, IL-6, IL-1β, and TNF-α, HC II antigen and mRNA levels were not changed; however, PAI-1 antigen and mRNA levels were clearly increased. These results suggest that the production of HC II in hepatoma cells is not regulated by the major inflammatory mediators, IL-6, IL-iβ, and TNF-α.

 

  • References

  • 1 Tollefsen DM, Majerus DW, Blank MK. Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. J Biol Chem 1982; 257: 2162-2169
    PubMedGoogle Scholar
  • 2 Tollefsen DM, Pestka CA, Monafo WJ. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem 1983; 258: 6713-6716
    PubMedGoogle Scholar
  • 3 Blinder MA, Marasa JC, Reynolds CH, Deaven LL, Tollefsen DM. Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coli. Biochem 1988; 27: 752-759
    CrossrefPubMedGoogle Scholar
  • 4 Jaffe EA, Armellino D, Tollefsen DM. Biosynthesis of functionally active heparin cofactor II by a human hepatoma-derived cell line. Biochem Biophys Res Commun 1985; 132: 368-374
    CrossrefPubMedGoogle Scholar
  • 5 Sandset PM, Andersson TR. Coagulation inhibitor levels in pneumonia and stroke: changes due to consumption and acute phase reaction. J Intern Med 1989; 225: 311-316
    CrossrefPubMedGoogle Scholar
  • 6 Toulon P, Vitoux JF, Fiessinger JN, Sicard D, Aiach M. Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis. Blood Coagulation and Fibrinolysis 1991; 2: 435-439
    CrossrefPubMedGoogle Scholar
  • 7 Kario K, Matsuo T, Kobayashi H. Heparin cofactor II deficiency in the elderly: comparison with antithrombin III. Thromb Res 1992; 66: 489-498
    CrossrefPubMedGoogle Scholar
  • 8 Bertina RM, van der Linden IK, Engesser L, Muller HP, Brommer EJ. Hereditary heparin cofactor II deficiency and the risk of development of thrombosis. Thromb Haemost 1987; 57: 196-200
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Morrone G, Ciliberto G, Oliviero S, Arcone R, Dente L, Content J, Cortese R. Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. J Biol Chem 1988; 263: 12554-12558
    PubMedGoogle Scholar
  • 10 Le J, Vilcek J. Interleukin A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989; 61: 588-602
    PubMedGoogle Scholar
  • 11 Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265: 621-636
    CrossrefPubMedGoogle Scholar
  • 12 Gauldie J, Sauder DN, McAdam KP, Dinarello CA. Purified interleukin-1 (IL-1) from human monocytes stimulates acute-phase protein synthesis by rodent hepatocytes in vitro. Immunol 1987; 60: 203-207
    PubMedGoogle Scholar
  • 13 Ramadori G, Sipe JD, Dinarello CA, Mizel SB, Colten HR. Pretransla-tional modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med 1985; 162: 930-942
    CrossrefPubMedGoogle Scholar
  • 14 Perlmutter DH, Dinarello CA, Punsal PI, Colten HR. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 1986; 78: 1349-1354
    CrossrefPubMedGoogle Scholar
  • 15 Andus T, Geiger T, Hirano T, Kishimoto T, Heinrich PC. Action of recombinant human interleukin 6, interleukin 1 beta and tumor necrosis factor alpha on the mRNA induction of acute-phase proteins. Eur J Immunol 1988; 18: 739-746
    CrossrefPubMedGoogle Scholar
  • 16 Baumann H, Wong GG. Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J Immunol 1989; 143: 1163-1167
    PubMedGoogle Scholar
  • 17 Mackiewicz A, Ganopathi MK, Schultz D, Brabence A, Weinstein J, Kelly MF, Kushner I. Transforming growth factor (3j regulates production of acute-phase proteins. Proc Natl Acad Sci USA 1990; 87: 1491-1495
    CrossrefPubMedGoogle Scholar
  • 18 Magielska-Zero D, Bereta J, Czuba-Pelech B, Pajdak W, Gauldie J, Koj A. Inhibitory effect of human recombinant interferon gamma on synthesis of acute phase proteins in human hepatoma Hep G2 cells stimulated by leukocyte cytokines, TNF alpha and IFN-beta 2/BSF-2/IL-6. Biochem Int 1988; 17: 17-23
    PubMedGoogle Scholar
  • 19 Baumann H, Richards C, Gauldie J. Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. J Immunol 1987; 139: 4122-4128
    PubMedGoogle Scholar
  • 20 Juhan-Vague I, Aillaud MF, de Cock F, Philip-Joet C, Amaud C, Serradimigni A, Collen D. The fast-acting inhibitor of tissue plasminogen activator is an acute phase reactant protein. In: Progress in Fibrinolysis.. Davidson JF, Donati MB, Coccheri S, eds. Churchill-Livingstone, Edinburgh 1985: 146
    PubMedGoogle Scholar
  • 21 de Boer JP, Abbink JJ, Brouwer MC, Meijer C, Roem D, Voom GP, Lambers JWJ, van Mourik JA, Hack CE. PAI-1 synthesis in the human hepatoma cell line Hep G2 is increased by cytokines - Evidence that the liver contributes to acute phase behavior of PAI-1. Thromb Haemost 1991; 65: 181-185
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Arndt A, Murphy P, Hart D. Human HuH-7 hepatoma cells express urokinase and plasminogen activator inhibitor-identification, characterization and regulation by inflammatory mediators. Biochem Biophys Acta 1992; 1138: 149-156
    CrossrefPubMedGoogle Scholar
  • 23 Yamagishi R, Niwa M, Kondo S, Sakuragawa N, Koide T. Purification and biological property of heparin cofactor II: Activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans. Thromb Res 1984; 36: 633-642
    CrossrefPubMedGoogle Scholar
  • 24 Hayakawa Y, Tazawa S, Ishikawa T-I, Niiya K, Sakuragawa N. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts. Thromb Haemost 1995; 74: 704-710
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 1982; 42: 3858-3863
    PubMedGoogle Scholar
  • 26 Nakabayashi H, Taketa K, Yamane T, Miyazaki M, Miyake K, Sato J. Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium. Gann 1984; 75: 151-158
    PubMedGoogle Scholar
  • 27 Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, a Laboratory Mannual, Second Edition: Cold Spring Harbor. Laboratory Press 1989 7. 19-17
    PubMedGoogle Scholar
  • 28 Hayakawa Y, Hayashi T, Niiya K, Sakuragawa N. Selective activation of heparin cofactor II by a sulfated polysaccharide isolated from the leaves of Artemisia princeps. Blood Coagul Fibrinolysis 1995; 6: 643-649
    CrossrefPubMedGoogle Scholar
  • 29 Lucore CL, Fujii S, Wun TC, Sobel BE, Billadello JJ. Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor. J Biol Chem 1988; 263: 15845-15848
    PubMedGoogle Scholar
  • 30 Vigano S, Mannucci PM, D’Angelo A, Gensini GF, Rostagno C, Neri Semeri GG. Protein C antigen is not an acute phase reactant and is often high in ischemic heart disease and diabetes. Thromb Haemost 1984; 52: 263-266
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Selinger MJ, McAdam KP, Kaplan MM, Sipe JD, Vogel SN, Rosenstreich DL. Monokine-induced synthesis of serum amyloid A protein by hepa-tocytes. Nature 1980; 285: 498-500
    CrossrefPubMedGoogle Scholar
  • 32 Baumann H, Jahreis GP, Sauder DN, Koj A. Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat, and mouse. J Biol Chem 1984; 259: 7331-7342
    PubMedGoogle Scholar
  • 33 Herzog R, Lutz S, Blin N, Marasa JC, Blinder MA, Tollefsen DM. Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22qll. Biochemistry 1991; 30: 1350-1357
    CrossrefPubMedGoogle Scholar
  • 34 Darlington GJ, Wilson DR, Lachman LB. Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J Cell Biol 1986; 103: 787-793
    CrossrefPubMedGoogle Scholar
  • 35 Fowlkes DM, Mullis NT, Comeau CM, Crabtree GR. Potential basis for regulation of the coordinately expressed fibrinogen genes: homology in the 5 flanking regions. Proc Natl Acad Sci USA 1984; 81: 2313-2316
    CrossrefPubMedGoogle Scholar
  • 36 Adrian GS, Korinek BW, Bowman BH, Yang F. The human transferrin gene: 5 region contains conserved sequences which match the control elements regulated by heavy metals, glucocorticoids and acute phase reaction. Gene 1986; 49: 167-175
    CrossrefPubMedGoogle Scholar
  • 37 Hoffman M, Pratt CW, Brown RL, Church FC. Heparin cofactor II-pro-teinase reaction products exhibit neutrophil chemoattractant activity. Blood 1989; 73: 1682-1685
    PubMedGoogle Scholar
  • 38 Church FC, Pratt CW, Hoffman M. Leukocyte chemoattractant peptides from the serpin heparin cofactor II. J Biol Chem 1991; 266: 704-709
    PubMedGoogle Scholar